Pharmaceutical Industry

letters

POGO Opposes Califf Nomination Due to Conflicts of Interest POGO and Coalition of Organizations Support Curbing Improper Payments Senate Considers Legislation to Help Stop Improper Payments POGO's Response to VA Inspector General's Subpoena for Whistleblower Records Public Comment on the Potential Release of Medicare Physician Data

Latest

At Least Half of Panel Advising Congress on Drug Policy Had Undisclosed Ties to Drug Makers

investigation | October 28, 2021

Latest

Discarded Drugs: Infrastructure Bill Leaves Cancer Patients by the Wayside

investigation | September 29, 2021

Avoiding the Subject: On Pfizer Vaccine Quality Control, FDA Says Less than European Counterpart

investigation | March 19, 2021
Hearing Without Listening

analysis | December 16, 2020
FDA Panel Reviewing Pfizer Vaccine Leaves Out Some Experts Who Raised Concerns

investigation | December 9, 2020
FDA Whitewashes Warnings About Coronavirus Vaccine Trials

analysis | November 2, 2020
HHS, Inc.: Big Pharma Ties Draw Pandemic Response Concerns

investigation | October 26, 2020
Some FDA Advisors Tapped to Review Coronavirus Vaccines Received Payments from Vaccine Companies

investigation | October 21, 2020
Coronavirus Relief Act Gives Drug Makers New Sway Over FDA

investigation | May 5, 2020
Following the (Drug) Money

investigation | May 5, 2020